Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Case report and review of the literature: ureteral endometriosis.

• Todd W. B. Gehr, Domenic A. Sica
• The American journal of the medical sciences
• 1987

Endometriosis is a common disorder affecting women of all ages. Although urinary tract involvement is not uncommon, ureteral obstruction is an infrequent complication of endometriosis. A case is… (More)

Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.

• Youhua Zhang, Zoran B Popović, +4 authors Todor N. Mazgalev
• Circulation. Heart failure
• 2009

BACKGROUND Autonomic dysfunction, characterized by sympathetic activation and vagal withdrawal, contributes to the progression of heart failure (HF). Although the therapeutic benefits of sympathetic… (More)

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

• John D. Bisognano, George L Bakris, +5 authors Domenic A. Sica
• Journal of the American College of Cardiology
• 2011

OBJECTIVES We sought to determine the effect of baroreflex activation therapy (BAT) on systolic blood pressure (SBP) in patients with resistant hypertension. BACKGROUND The Rheos Pivotal Trial… (More)

Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High…

• Anton C. Schoolwerth, Domenic A. Sica, Barbara J Ballermann, Christopher Stuart Wilcox
• Circulation
• 2001

Angiotensin converting enzyme (ACE) inhibitors are now one of the most frequently used classes of antihypertensive drugs. Beyond their utility in the management of hypertension, their use has been… (More)

Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss.

• Harvey J. Sugerman, Luke G. Wolfe, Domenic A. Sica, John N. Clore
• Annals of surgery
• 2003

OBJECTIVE To evaluate the preoperative relationships of hypertension and diabetes mellitus in severe obesity and the effects of gastric bypass (GBP)-induced weight loss. SUMMARY BACKGROUND DATA… (More)

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

• Gary R. Matzke, George R. Aronoff, +16 authors Patrick E. Murray
• Kidney international
• 2011

Drug dosage adjustment for patients with acute or chronic kidney disease is an accepted standard of practice. The challenge is how to accurately estimate a patient's kidney function in both acute and… (More)

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

• Janice G. Douglas, George L Bakris, +13 authors Donald G. Vidt
• Archives of internal medicine
• 2003

Janice G. Douglas, MD; George L. Bakris, MD; Murray Epstein, MD; Keith C. Ferdinand, MD; Carlos Ferrario, MD; John M. Flack, MD, MPH; Kenneth A. Jamerson, MD; Wendell E. Jones, MD; Julian Haywood,… (More)

Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

• John M. Flack, Domenic A. Sica, +12 authors Kenneth A. Jamerson
• Hypertension
• 2010

Since the first International Society on Hypertension in Blacks consensus statement on the "Management of High Blood Pressure in African American" in 2003, data from additional clinical trials have… (More)

Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.

• Siddhartha Sankar Ghosh, Hugh Davis Massey, +5 authors Todd W. B. Gehr
• American journal of physiology. Renal physiology
• 2009

TNF-alpha and NF-kappaB play important roles in the development of inflammation in chronic renal failure (CRF). In hepatic cells, curcumin is shown to antagonize TNF-alpha-elicited NF-kappaB… (More)

Clinical pharmacokinetics of losartan.

• Domenic A. Sica, Todd W. B. Gehr, Siddhartha Ghosh
• Clinical pharmacokinetics
• 2005

Losartan is the first orally available angiotensin-receptor antagonist without agonist properties. Following oral administration, losartan is rapidly absorbed, reaching maximum concentrations 1-2… (More)

• ‹
• 1
• 2
• 3
• 4
• 5
• ›